PRPH Share Price

Open 2.01 Change Price %
High 2.01 1 Day 0.04 2.06
Low 1.97 1 Week 0.03 1.54
Close 1.98 1 Month -0.01 -0.50
Volume 4500 1 Year 0.64 47.76
52 Week High 2.24
52 Week Low 0.00
PRPH Important Levels
Resistance 2 2.02
Resistance 1 2.00
Pivot 1.99
Support 1 1.96
Support 2 1.94
NASDAQ USA Most Active Stocks
SIRI 4.30 -5.49%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
QQQ 115.70 0.20%
WRES 0.09 0.00%
More..
NASDAQ USA Top Gainers Stocks
QKLS 0.21 110.00%
LOCM 0.09 50.00%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
PERF 1.90 22.58%
ASNA 7.01 20.24%
SBSA 4.60 17.95%
CEMP 7.55 15.27%
XXIA 15.55 14.76%
More..
NASDAQ USA Top Losers Stocks
PTIX 0.00 -100.00%
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
AMCF 0.03 -50.00%
VALV 0.03 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
RITT 0.06 -45.45%
More..

ProPhase Labs, Inc. (NASDAQ: PRPH)

PRPH Technical Analysis 2
As on 2nd Dec 2016 PRPH Share Price closed @ 1.98 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 1.56 & Sell for SHORT-TERM with Stoploss of 2.00 we also expect STOCK to react on Following IMPORTANT LEVELS.
PRPH Target for December
1st Target up-side 2.11
2nd Target up-side 2.18
3rd Target up-side 2.24
1st Target down-side 1.93
2nd Target down-side 1.86
3rd Target down-side 1.8
PRPH Other Details
Segment EQ
Market Capital 23589780.00
Sector Consumer Durables Major Pharmaceuticals
Industry
Offical website
PRPH Address
PRPH
N/A
PRPH Latest News
Can This Stock Build Some Momentum: ProPhase Labs Inc. (PRPH)   MicroCap Wired   - 01st Dec 16
Company Watch for ProPhase Labs, Inc. (NASDAQ:PRPH)   Liberty News   - 01st Dec 16
PROPHASE LABS, INC. (NASDAQ:PRPH) Files An 8-K Other Events   Market Exclusive   - 17th Nov 16
ProPhase Labs (PRPH) Reports Positive Verdict in Ongoing Phosphagenics Arbitration   StreetInsider.com   - 17th Nov 16
ProPhase Labs Inc. (PRPH) Posts Quarterly Earnings Results   Marea Informative   - 16th Nov 16
Form 8-K ProPhase Labs, Inc. For: Nov 14   StreetInsider.com   - 16th Nov 16
ProPhase Labs Inc. (PRPH) Posts Earnings Results   Community Financial News   - 15th Nov 16
ProPhase Labs Inc. (PRPH) Announces Quarterly Earnings Results   The Cerbat Gem   - 14th Nov 16
ProPhase Labs: One Hit Wonder Or About To Explode?   Seeking Alpha   - 21st Jun 16
Cold-Eeze CEO speaks about firm's new male sex drive pill   Philly.com   - 29th Jan 16
Interactive Technical Analysis Chart ProPhase Labs, Inc. ( PRPH NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on ProPhase Labs, Inc.
PRPH Business Profile
ProPhase Labs, Inc. is a manufacturer, marketer and distributor of a ranges of homeopathic and health products that are offered to the general public. The Company is also engaged in the research and development of potential over-the-counter (OTC) drugs, natural base health products along with supplements, personal care and cosmeceutical products. The Company's primary business is manufacturing, distribution, marketing and selling of OTC cold remedy products to consumers through food, multi-outlet pharmacy and chain drug stores, wholesalers and mass merchandisers. The Company's brand is Cold-EEZEO Cold Remedy and the Company's principal product is Cold-EEZEO zinc gluconate lozenges, used to reduce the duration and severity of symptoms of the common cold. In August 2011, the Company launched Cold-EEZE Oral Spray.